|
Dr. Mark Young, an author and expert in pain management, will lead the free health event, discussing ways to help relieve the painful symptoms of diabetic nerve pain.
Dr. Mark Young and a local spokesperson will be available for in-studio/print interviews while they are in each city to discuss:
* Steps for Healthy Living Event: While there is no treatment to eliminate diabetic nerve pain, this event will highlight treatment options and simple lifestyle changes that may help manage the pain.
* Knowing Symptoms: People living with diabetes may not recognize the symptoms of diabetic nerve pain such as a burning, shooting, or stabbing pain in their hands and feet, or realize that it can be treated.
* Getting Back to Doing the Simple Things: Diabetic nerve pain can make people feel old before their time, but there are treatments that may help them get back to doing things affected by the pain.
Mark Allen Young, MD, MBA, FACP, is a board-certified specialist in Physical Medicine and Rehabilitation and a licensed acupuncturist. His sub-specialty interest is pain management and he currently serves as Chairman of the Department of Physical Medicine and Rehabilitation at the Maryland Rehabilitation Center. He is presently Editor-in-Chief of the Journal of Practical Pain Management.
Below is the schedule of events:
New York, NY
November 13, 2007
North General Hospital
5:30 - 8:00 p.m.
Washington, D.C.
November 15, 2007
King Greenleaf Community Center
11:30 - 2:30 p.m.
Chicago, IL
November 27, 2007
Homan Square Park
11:30 - 2:30 p.m.
Indianapolis, IN
November 28, 2007
Brookside Park Community Center
11:30 - 2:30 p.m.
Detroit, MI
December 4, 2007
Detroit Area Agency on Aging
11:30 - 2:30 p.m.
Dallas, TX
December 11, 2007
Martin Luther King, Jr. Community Center
11:30 - 2:30 p.m.
Tampa, FL
December 13, 2007
Barksdale Community Center
12:00 - 3:00 p.m.
Houston, TX
January 2008
Sunnyside Community Center
11:30 - 2:30 p.m.
Visit www.Cymbalta.com/StepsForHealthyLiving for information on how to register for these events.
This event is sponsored by Eli Lilly and Company. For more information about the events and diabetic nerve pain, visit www.Cymbalta.com/DPNP
To schedule an interview contact Alice McGrail at 212-884-0658 or amcgrail@chamberlainpr.com.
About Diabetic Nerve Pain
Approximately 5 million people are affected by diabetic nerve pain. People who have high blood sugar levels, high blood pressure, increased weight, who smoke, or are over the age of 40, may have a greater risk of developing diabetic nerve pain. Symptoms can include numbness, tingling or weakness in the feet and legs, and sometimes the hands and arms. Unfortunately while the majority of people with diabetes experience symptoms of diabetic nerve pain, only 56 percent of patients have ever heard of the condition.(2)
Important Safety Information
Cymbalta is approved to treat major depressive disorder and generalized anxiety disorder and manage diabetic peripheral neuropathic pain. Antidepressants can increase suicidal thoughts and behaviors in children, adolescents and young adults. Patients should call their doctor right away if they experience worsening depression symptoms, unusual changes in behavior or thoughts of suicide. Be especially observant within the first few months of treatment or after a change in dose. Cymbalta is approved only for adults 18 and over.
Cymbalta is not for everyone. Patients should not take Cymbalta if they have recently taken a type of antidepressant called a monoamine oxidase inhibitor (MAOI), are taking Mellaril® (thioridazine) or have uncontrolled glaucoma. Patients should speak with their doctor about all medicines they are taking, including those for migraine to avoid a potentially life-threatening condition. Patients should tell their doctor about their alcohol consumption, if they have liver disease, and about all of their medical conditions.
Patients taking Cymbalta may experience dizziness or fainting upon standing. The most common side effects of Cymbalta include:
* For MDD: Nausea, dry mouth and constipation
* For DPNP: Nausea, somnolence (sleepiness), dizziness and constipation
* For GAD: Nausea, fatigue, dry mouth, somnolence and constipation
This is not a complete list of side effects.
For full Patient Information, visit www.cymbalta.com
For full Prescribing Information, including Boxed Warning, visit http://www.cymbalta.com/
Reply to Mediaoptout@lilly.com if you do not wish to receive media announcements via e-mail in the future.
Or reply to:
Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285
Attn: Global Product Communications
Drop Code 4925
1. Centers for Disease Control and Prevention. "Number of (in Millions) of Persons with Diagnosed Diabetes, United States, 1980 – 2005." Available at: http://www.cdc.gov/diabetes/statistics/prev/national/figpersons.htm. Accessed on October 30, 2007.
2. "American Diabetes Association Survey Finds Most People with Diabetes Don't Know About Highly Prevalent, Serious Complication.” Available at http://www.diabetes.org/for-media/2005-press-releases/diabeticneuropathy.jsp. Accessed on April 12, 2007.
CONTACT:
Alice McGrail
212-884-0658
amcgrail@chamberlainpr.com
|
Email
This Article To A Friend
